Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility, Efficacy And Safety Of De Novo Extended-Release Tacrolimus Following Liver Transplantation

NCT05242315 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT05242315
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05242315 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility, Efficacy And Safety Of De Novo Extended-Release Tacrolimus Following Liver Transplantation
Lead sponsor
University of Alberta
Phase
Phase 4
Overall status
Recruiting
Start date
May 15, 2022
Completion date
February 15, 2034
Enrollment
94 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, immunosuppressant adverse reaction, liver transplant; complications, metabolic syndrome, renal insufficiency